NCI’s Consumer Liaison Group Chooses Four Areas of Concern
BETHESDA, Md--The new consumer liaison group to the NCI director has chosen three of its 15 members to serve as co-chairs and has identified four areas of concern for its initial attention.
BETHESDA, Md--The new consumer liaison group to the NCI director has chosen three of its 15 members to serve as co-chairs and has identified four areas of concern for its initial attention.
The co-chairs are M. Venus Gines, a breast-cancer survivor from Lithonia, Ga, active in community work with the American Cancer Society; Susan A. Leigh of Tucson, Ariz, a survivor of Hodgkins disease, breast cancer, and bladder cancer, and active in the National Coalition for Cancer Survivorship and the Oncology Nursing Society; and Daniel M. Moore, Jr., a prostate cancer survivor from Decatur, Ill, who started the Central Illinois US TOO! prostate cancer support group.
The consumer groups four areas of immediate concern are communications and immediate access to reliable cancer information; informed consent, including making forms more understandable; patient consumer issues and population and genetics studies; and ways to identify additional consumer representatives for NCI committees and groups.
Gedatolisib Combo With/Without Palbociclib May Be New SOC in PIK3CA Wild-Type Breast Cancer
December 21st 2025“VIKTORIA-1 is the first study to demonstrate a statistically significant and clinically meaningful improvement in PFS with PAM inhibition in patients with PIK3CA wild-type disease, all of whom received prior CDK4/6 inhibition,” said Barbara Pistilli, MD.
